Navigation Links
Vaccine for brain tumors shows promising results

A vaccine for treating a recurrent cancer of the central nervous system that occurs primarily in the brain, known as glioma, has shown promising results in preliminary data from a clinical trial at UCSF Medical Center.

Findings from the first group of six patients in the study, being conducted at the UCSF Brain Tumor Research Center, showed that vitespen (trademarked as Oncophage), a vaccine made from the patient's own tumor, was associated with tumor-specific immune response in patients with recurrent, high-grade glioma.

Glioma is a type of primary tumor that arises from the glial cells, the connective tissue cells that surround and support nerve cells. The most common site of involvement of a glioma is the brain. Malignant glioma is currently a fatal disease.

The trial results are being presented at the Immunotherapy Task Force Meeting, sponsored by the Society of Neuro-Oncology and the Joint Section of Tumors, during the Society's 11th annual scientific meeting in Orlando, Fla., on November 16, 2006.

"This is the first documentation of a glioma-specific immune response after vaccination with vitespen," said Andrew T. Parsa, MD, PhD, assistant professor in the UCSF Department of Neurological Surgery and principal investigator of the trial.

"Based on preliminary observation of patients in the first cohort, the tumor-specific immune response evoked by vitespen vaccination may be associated with clinical benefit in these patients with recurrent glioma, including improved progression-free survival and overall survival compared with historical controls. Further studies are certainly warranted to definitively determine the benefit of vitespen in this patient population," he said.

Derived from each individual's tumor, vitespen contains the "fingerprint" of the patient's particular cancer and is designed to reprogram the body's immune system to target only cancer cells bearing this fingerprint. The vaccine is
'"/>

Source:University of California - San Francisco


Page: 1 2 3

Related biology news :

1. FDA Approves Human Hookworm Vaccine for Phase I Safety Trials
2. Live Recombinant Adenovirus Vaccine Technique Explored
3. Gene Vaccine Protects Mice Against Development Of Her2/neu Breast Cancer
4. NIAID Initiates Trial of Experimental Avian Flu Vaccine
5. Study Models Impact Of Anthrax Vaccine
6. New Insights Into HIV Immunity Suggest Alternative Approach to Vaccines
7. Pathogen-Mimicking Vaccine As Strategy For Cancer Therapy
8. EuroVacc 02 HIV Vaccine Trial Begins
9. Active Vaccine Prevents Mice From Developing Prion Disease
10. New Vaccine To Be Used For First Time In Polio Outbreak Response
11. Boosting The BCG Vaccine To Beat Tuberculosis

Post Your Comments:
(Date:12/2/2009)..., , REDWOOD SHORES, Calif. and P... Communication Intelligence Corporation ("CIC") (O...ectronic signature solutions for business process ...gnized leader** in biometric signature verificatio...g International Electronic Document Management (ED...
(Date:12/2/2009)..., New York, NY, December 2, 2009 Commonly prescr...ment of asthma in pregnant women as well as pre-te...trum disorders, psychiatric pathology, cognitive p...ren, according to a new study published in the Dec...trics & Gynecology . , Beta 2 adrenergic agonist...
(Date:12/2/2009)..., , (Dec. 2, 2009) HOBOKEN, NJ According to the...rcent of Americans diagnosed with diabetes already...c retinopathy, damage to the retina caused by leak...people with diabetes and is one of the most feared...t of all patients who,ve had diabetes for 10 years...
Breaking Biology News(10 mins):CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 3CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 4Treatments for asthma and pre-term labor may increase risk of autism in developing fetus 2Study shows pine bark improves circulation, swelling and visual acuity in early diabetic retinopathy 2Study shows pine bark improves circulation, swelling and visual acuity in early diabetic retinopathy 3Tolerx Presents Data at 69th Scientific Sessions of the American Diabetes Association 4562 1Tolerx Presents Data at 69th Scientific Sessions of the American Diabetes Association 4562 2Tolerx Presents Data at 69th Scientific Sessions of the American Diabetes Association 4562 3LSUHSC researchers first to document early signs for diabetes in kids as young as 7 48185 1LSUHSC researchers first to document early signs for diabetes in kids as young as 7 48185 2LSUHSC researchers first to document early signs for diabetes in kids as young as 7 48185 3Researchers shed light on trading behavior in animals and humans 8746 1Researchers shed light on trading behavior in animals and humans 8746 2
...wo-year study of college students at The Pennsylva...arn better and develop higher-level skills by part...ed to traditional classroom teaching methods. , E...partment of Horticulture at PSU, surveyed students...s course. The specialized course was designed arou...
...it fresh, canned and frozen. It,s grown in every s... the American Society of Horticultural Science, ad... in the U.S. In other words, sweet corn is big bus... the U.S. peaks in July, with only ten percent of ...resh sweet corn is extremely perishable as a resul...
...tary molecules found in legumes and bran could pro...searchers from the University of Maryland report. ...d both human skin cells and a skin cancer-prone mo..., the damaging radiation found in sunlight, the te...Cancer Research Centennial Conference on Translati...
Other Biology News:Teamwork improves learning and career success 2How sweet is it? 2Antioxidants could provide all-purpose radiation protection 2Antioxidants could provide all-purpose radiation protection 3
(Date:12/2/2009)... , TUSTIN, Calif., Dec. 2 /PRNewswire-First... PPHM ) today reported completion of patient enrol...f Cotara® in patients with relapsed glioblast...cancer. Cotara is a targeted monoclonal antibody ...ntial new treatment for GBM. Cotara specifically ...
(Date:12/2/2009)... , JERUSALEM, Israel, December 2 /P...ility study evaluating the preclinical (animal stu...which combines technology from Weill,Cornell Medic...otential to,treat inherited anemias such as Cooley...series of technologies to expand, ex vivo,populat...
(Date:12/2/2009)... , SHANGHAI, Dec. 2 /PRNewswire-Asia/ -...markets are in turmoil and uncertainty is part of ...the pharma industry has been,relatively immune to ...e a,vacation. , During the midst of the d... Johnson & Johnson inaugurated an R&D cent...
(Date:12/1/2009)... , NEW YORK, Dec. 1 Repo...report is available in its catalogue: ,, Chro...portlinker.com/p0164494/Chromium---Global-Market-T... primarily influenced by stainless steel, while gr...ts is also important for growth of chromium metal....
Breaking Biology Technology:Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3Reportlinker Adds Chromium - Global Market Trends 2Reportlinker Adds Chromium - Global Market Trends 3Reportlinker Adds Chromium - Global Market Trends 4Reportlinker Adds Chromium - Global Market Trends 5Reportlinker Adds Chromium - Global Market Trends 6Reportlinker Adds Chromium - Global Market Trends 7Reportlinker Adds Chromium - Global Market Trends 8Reportlinker Adds Chromium - Global Market Trends 9
... SolvayCARES Thriving Student Achiever and ...ETTA, Ga., Sept. 15 Solvay Pharmaceuticals, Inc.,...tudents living with,cystic fibrosis (CF) through i...as received a one-year award of $2,500 to help fin...ayCARES Scholarship winner,will go on to earn the ...
...ores Need for Better Understanding of Impl...MONTREAL, Sept. 15 Results from the Global Longit...d that 55 percent of women,diagnosed with osteopor...ractures than their peers. This latest study from ...nd was presented today at the American Society,for...
...ted,(Nasdaq: VICL ) presentation at the UBS Globa..., at 1 p.m. Eastern Daylight Time, will be availab... page at http://www.vical.com ., About Vical, V...ducts based on its,patented DNA delivery technolog... life-threatening diseases. Potential applications...
Other Biology Technology:40 High-Achieving Students with Cystic Fibrosis Receive $100,000 Total in Higher Education Scholarships From SolvayCARES(SM) 240 High-Achieving Students with Cystic Fibrosis Receive $100,000 Total in Higher Education Scholarships From SolvayCARES(SM) 340 High-Achieving Students with Cystic Fibrosis Receive $100,000 Total in Higher Education Scholarships From SolvayCARES(SM) 4Global Study Shows That Majority of Women with Osteoporosis Do Not Consider Themselves at Higher Risk for Fractures 2Global Study Shows That Majority of Women with Osteoporosis Do Not Consider Themselves at Higher Risk for Fractures 3Vical to Present at UBS Global Life Sciences Conference 2
...g a clone of the human Topoisomerase II gene. ...al state of nucleic acids by passing an intact DNA... separate DNA helix (1,2) . As a result of its dou... relax negatively or positively supercoiled DNA, a...
Reverse Transcriptase AMV; RNA dependent DNA polymerase from Roche Applied Science
Shake 'n' Stack w/ Shaking Platform from Thermo Scientific
DNA Polymerase I, E. coli from EPICENTRE Biotechnologies
Biology Products: